 | • レポートコード：MRC308GR09502 • 出版社/出版日：GlobalInfoResearch / 2023年8月 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界の初代CD56+NK細胞の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の初代CD56+NK細胞市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– 初代CD56+NK細胞の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
初代CD56+NK細胞市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・オーダーメイド、バルク
用途別セグメント
・化合物スクリーニング、免疫機能検査、創薬、その他
主要な市場プレーヤー
・PBM、ATCC、STEMCEITM、Thermo Fisher Scientific、AllCells、ABM、3H Biomedical、ProMab Biotechnologies、AcceGen、AMSBIO、Clinisciences、Creative Bioarray、iCell Bioscience、Shenzhen Kingfocus Biomedical
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、初代CD56+NK細胞製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な初代CD56+NK細胞メーカーの企業概要、2019年～2022年までの初代CD56+NK細胞の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な初代CD56+NK細胞メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別初代CD56+NK細胞の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの初代CD56+NK細胞の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での初代CD56+NK細胞市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および初代CD56+NK細胞の産業チェーンを掲載しています。
・第14、15章では、初代CD56+NK細胞の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– 初代CD56+NK細胞の概要
– 種類別分析（2018年vs2022年vs2029年）：オーダーメイド、バルク
– 用途別分析（2018年vs2022年vs2029年）：化合物スクリーニング、免疫機能検査、創薬、その他
– 世界の初代CD56+NK細胞市場規模・予測
– 世界の初代CD56+NK細胞生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– PBM、ATCC、STEMCEITM、Thermo Fisher Scientific、AllCells、ABM、3H Biomedical、ProMab Biotechnologies、AcceGen、AMSBIO、Clinisciences、Creative Bioarray、iCell Bioscience、Shenzhen Kingfocus Biomedical
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：オーダーメイド、バルク
・用途別分析2018年-2029年：化合物スクリーニング、免疫機能検査、創薬、その他
・初代CD56+NK細胞の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・初代CD56+NK細胞のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・初代CD56+NK細胞のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・初代CD56+NK細胞の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・初代CD56+NK細胞の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Primary CD56+ NK Cells
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Primary CD56+ NK Cells Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Custom Made
1.3.3 Bulk
1.4 Market Analysis by Application
1.4.1 Overview: Global Primary CD56+ NK Cells Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Compound Screening
1.4.3 Immune Function Assay
1.4.4 Drug Discovery
1.4.5 Others
1.5 Global Primary CD56+ NK Cells Market Size & Forecast
1.5.1 Global Primary CD56+ NK Cells Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Primary CD56+ NK Cells Sales Quantity (2018-2029)
1.5.3 Global Primary CD56+ NK Cells Average Price (2018-2029)
2 Manufacturers Profiles
2.1 PBM
2.1.1 PBM Details
2.1.2 PBM Major Business
2.1.3 PBM Primary CD56+ NK Cells Product and Services
2.1.4 PBM Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 PBM Recent Developments/Updates
2.2 ATCC
2.2.1 ATCC Details
2.2.2 ATCC Major Business
2.2.3 ATCC Primary CD56+ NK Cells Product and Services
2.2.4 ATCC Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 ATCC Recent Developments/Updates
2.3 STEMCEITM
2.3.1 STEMCEITM Details
2.3.2 STEMCEITM Major Business
2.3.3 STEMCEITM Primary CD56+ NK Cells Product and Services
2.3.4 STEMCEITM Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 STEMCEITM Recent Developments/Updates
2.4 Thermo Fisher Scientific
2.4.1 Thermo Fisher Scientific Details
2.4.2 Thermo Fisher Scientific Major Business
2.4.3 Thermo Fisher Scientific Primary CD56+ NK Cells Product and Services
2.4.4 Thermo Fisher Scientific Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Thermo Fisher Scientific Recent Developments/Updates
2.5 AllCells
2.5.1 AllCells Details
2.5.2 AllCells Major Business
2.5.3 AllCells Primary CD56+ NK Cells Product and Services
2.5.4 AllCells Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AllCells Recent Developments/Updates
2.6 ABM
2.6.1 ABM Details
2.6.2 ABM Major Business
2.6.3 ABM Primary CD56+ NK Cells Product and Services
2.6.4 ABM Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 ABM Recent Developments/Updates
2.7 3H Biomedical
2.7.1 3H Biomedical Details
2.7.2 3H Biomedical Major Business
2.7.3 3H Biomedical Primary CD56+ NK Cells Product and Services
2.7.4 3H Biomedical Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 3H Biomedical Recent Developments/Updates
2.8 ProMab Biotechnologies
2.8.1 ProMab Biotechnologies Details
2.8.2 ProMab Biotechnologies Major Business
2.8.3 ProMab Biotechnologies Primary CD56+ NK Cells Product and Services
2.8.4 ProMab Biotechnologies Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 ProMab Biotechnologies Recent Developments/Updates
2.9 AcceGen
2.9.1 AcceGen Details
2.9.2 AcceGen Major Business
2.9.3 AcceGen Primary CD56+ NK Cells Product and Services
2.9.4 AcceGen Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 AcceGen Recent Developments/Updates
2.10 AMSBIO
2.10.1 AMSBIO Details
2.10.2 AMSBIO Major Business
2.10.3 AMSBIO Primary CD56+ NK Cells Product and Services
2.10.4 AMSBIO Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 AMSBIO Recent Developments/Updates
2.11 Clinisciences
2.11.1 Clinisciences Details
2.11.2 Clinisciences Major Business
2.11.3 Clinisciences Primary CD56+ NK Cells Product and Services
2.11.4 Clinisciences Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Clinisciences Recent Developments/Updates
2.12 Creative Bioarray
2.12.1 Creative Bioarray Details
2.12.2 Creative Bioarray Major Business
2.12.3 Creative Bioarray Primary CD56+ NK Cells Product and Services
2.12.4 Creative Bioarray Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Creative Bioarray Recent Developments/Updates
2.13 iCell Bioscience
2.13.1 iCell Bioscience Details
2.13.2 iCell Bioscience Major Business
2.13.3 iCell Bioscience Primary CD56+ NK Cells Product and Services
2.13.4 iCell Bioscience Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 iCell Bioscience Recent Developments/Updates
2.14 Shenzhen Kingfocus Biomedical
2.14.1 Shenzhen Kingfocus Biomedical Details
2.14.2 Shenzhen Kingfocus Biomedical Major Business
2.14.3 Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Product and Services
2.14.4 Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Shenzhen Kingfocus Biomedical Recent Developments/Updates
3 Competitive Environment: Primary CD56+ NK Cells by Manufacturer
3.1 Global Primary CD56+ NK Cells Sales Quantity by Manufacturer (2018-2023)
3.2 Global Primary CD56+ NK Cells Revenue by Manufacturer (2018-2023)
3.3 Global Primary CD56+ NK Cells Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Primary CD56+ NK Cells by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Primary CD56+ NK Cells Manufacturer Market Share in 2022
3.4.2 Top 6 Primary CD56+ NK Cells Manufacturer Market Share in 2022
3.5 Primary CD56+ NK Cells Market: Overall Company Footprint Analysis
3.5.1 Primary CD56+ NK Cells Market: Region Footprint
3.5.2 Primary CD56+ NK Cells Market: Company Product Type Footprint
3.5.3 Primary CD56+ NK Cells Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Primary CD56+ NK Cells Market Size by Region
4.1.1 Global Primary CD56+ NK Cells Sales Quantity by Region (2018-2029)
4.1.2 Global Primary CD56+ NK Cells Consumption Value by Region (2018-2029)
4.1.3 Global Primary CD56+ NK Cells Average Price by Region (2018-2029)
4.2 North America Primary CD56+ NK Cells Consumption Value (2018-2029)
4.3 Europe Primary CD56+ NK Cells Consumption Value (2018-2029)
4.4 Asia-Pacific Primary CD56+ NK Cells Consumption Value (2018-2029)
4.5 South America Primary CD56+ NK Cells Consumption Value (2018-2029)
4.6 Middle East and Africa Primary CD56+ NK Cells Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
5.2 Global Primary CD56+ NK Cells Consumption Value by Type (2018-2029)
5.3 Global Primary CD56+ NK Cells Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
6.2 Global Primary CD56+ NK Cells Consumption Value by Application (2018-2029)
6.3 Global Primary CD56+ NK Cells Average Price by Application (2018-2029)
7 North America
7.1 North America Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
7.2 North America Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
7.3 North America Primary CD56+ NK Cells Market Size by Country
7.3.1 North America Primary CD56+ NK Cells Sales Quantity by Country (2018-2029)
7.3.2 North America Primary CD56+ NK Cells Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
8.2 Europe Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
8.3 Europe Primary CD56+ NK Cells Market Size by Country
8.3.1 Europe Primary CD56+ NK Cells Sales Quantity by Country (2018-2029)
8.3.2 Europe Primary CD56+ NK Cells Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Primary CD56+ NK Cells Market Size by Region
9.3.1 Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Primary CD56+ NK Cells Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
10.2 South America Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
10.3 South America Primary CD56+ NK Cells Market Size by Country
10.3.1 South America Primary CD56+ NK Cells Sales Quantity by Country (2018-2029)
10.3.2 South America Primary CD56+ NK Cells Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Primary CD56+ NK Cells Market Size by Country
11.3.1 Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Primary CD56+ NK Cells Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Primary CD56+ NK Cells Market Drivers
12.2 Primary CD56+ NK Cells Market Restraints
12.3 Primary CD56+ NK Cells Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Primary CD56+ NK Cells and Key Manufacturers
13.2 Manufacturing Costs Percentage of Primary CD56+ NK Cells
13.3 Primary CD56+ NK Cells Production Process
13.4 Primary CD56+ NK Cells Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Primary CD56+ NK Cells Typical Distributors
14.3 Primary CD56+ NK Cells Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Primary CD56+ NK Cells Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Primary CD56+ NK Cells Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. PBM Basic Information, Manufacturing Base and Competitors
Table 4. PBM Major Business
Table 5. PBM Primary CD56+ NK Cells Product and Services
Table 6. PBM Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. PBM Recent Developments/Updates
Table 8. ATCC Basic Information, Manufacturing Base and Competitors
Table 9. ATCC Major Business
Table 10. ATCC Primary CD56+ NK Cells Product and Services
Table 11. ATCC Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. ATCC Recent Developments/Updates
Table 13. STEMCEITM Basic Information, Manufacturing Base and Competitors
Table 14. STEMCEITM Major Business
Table 15. STEMCEITM Primary CD56+ NK Cells Product and Services
Table 16. STEMCEITM Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. STEMCEITM Recent Developments/Updates
Table 18. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 19. Thermo Fisher Scientific Major Business
Table 20. Thermo Fisher Scientific Primary CD56+ NK Cells Product and Services
Table 21. Thermo Fisher Scientific Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Thermo Fisher Scientific Recent Developments/Updates
Table 23. AllCells Basic Information, Manufacturing Base and Competitors
Table 24. AllCells Major Business
Table 25. AllCells Primary CD56+ NK Cells Product and Services
Table 26. AllCells Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. AllCells Recent Developments/Updates
Table 28. ABM Basic Information, Manufacturing Base and Competitors
Table 29. ABM Major Business
Table 30. ABM Primary CD56+ NK Cells Product and Services
Table 31. ABM Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. ABM Recent Developments/Updates
Table 33. 3H Biomedical Basic Information, Manufacturing Base and Competitors
Table 34. 3H Biomedical Major Business
Table 35. 3H Biomedical Primary CD56+ NK Cells Product and Services
Table 36. 3H Biomedical Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. 3H Biomedical Recent Developments/Updates
Table 38. ProMab Biotechnologies Basic Information, Manufacturing Base and Competitors
Table 39. ProMab Biotechnologies Major Business
Table 40. ProMab Biotechnologies Primary CD56+ NK Cells Product and Services
Table 41. ProMab Biotechnologies Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. ProMab Biotechnologies Recent Developments/Updates
Table 43. AcceGen Basic Information, Manufacturing Base and Competitors
Table 44. AcceGen Major Business
Table 45. AcceGen Primary CD56+ NK Cells Product and Services
Table 46. AcceGen Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. AcceGen Recent Developments/Updates
Table 48. AMSBIO Basic Information, Manufacturing Base and Competitors
Table 49. AMSBIO Major Business
Table 50. AMSBIO Primary CD56+ NK Cells Product and Services
Table 51. AMSBIO Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. AMSBIO Recent Developments/Updates
Table 53. Clinisciences Basic Information, Manufacturing Base and Competitors
Table 54. Clinisciences Major Business
Table 55. Clinisciences Primary CD56+ NK Cells Product and Services
Table 56. Clinisciences Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Clinisciences Recent Developments/Updates
Table 58. Creative Bioarray Basic Information, Manufacturing Base and Competitors
Table 59. Creative Bioarray Major Business
Table 60. Creative Bioarray Primary CD56+ NK Cells Product and Services
Table 61. Creative Bioarray Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Creative Bioarray Recent Developments/Updates
Table 63. iCell Bioscience Basic Information, Manufacturing Base and Competitors
Table 64. iCell Bioscience Major Business
Table 65. iCell Bioscience Primary CD56+ NK Cells Product and Services
Table 66. iCell Bioscience Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. iCell Bioscience Recent Developments/Updates
Table 68. Shenzhen Kingfocus Biomedical Basic Information, Manufacturing Base and Competitors
Table 69. Shenzhen Kingfocus Biomedical Major Business
Table 70. Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Product and Services
Table 71. Shenzhen Kingfocus Biomedical Primary CD56+ NK Cells Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Shenzhen Kingfocus Biomedical Recent Developments/Updates
Table 73. Global Primary CD56+ NK Cells Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 74. Global Primary CD56+ NK Cells Revenue by Manufacturer (2018-2023) & (USD Million)
Table 75. Global Primary CD56+ NK Cells Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 76. Market Position of Manufacturers in Primary CD56+ NK Cells, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 77. Head Office and Primary CD56+ NK Cells Production Site of Key Manufacturer
Table 78. Primary CD56+ NK Cells Market: Company Product Type Footprint
Table 79. Primary CD56+ NK Cells Market: Company Product Application Footprint
Table 80. Primary CD56+ NK Cells New Market Entrants and Barriers to Market Entry
Table 81. Primary CD56+ NK Cells Mergers, Acquisition, Agreements, and Collaborations
Table 82. Global Primary CD56+ NK Cells Sales Quantity by Region (2018-2023) & (K Units)
Table 83. Global Primary CD56+ NK Cells Sales Quantity by Region (2024-2029) & (K Units)
Table 84. Global Primary CD56+ NK Cells Consumption Value by Region (2018-2023) & (USD Million)
Table 85. Global Primary CD56+ NK Cells Consumption Value by Region (2024-2029) & (USD Million)
Table 86. Global Primary CD56+ NK Cells Average Price by Region (2018-2023) & (US$/Unit)
Table 87. Global Primary CD56+ NK Cells Average Price by Region (2024-2029) & (US$/Unit)
Table 88. Global Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Global Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Global Primary CD56+ NK Cells Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Global Primary CD56+ NK Cells Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Global Primary CD56+ NK Cells Average Price by Type (2018-2023) & (US$/Unit)
Table 93. Global Primary CD56+ NK Cells Average Price by Type (2024-2029) & (US$/Unit)
Table 94. Global Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Global Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Global Primary CD56+ NK Cells Consumption Value by Application (2018-2023) & (USD Million)
Table 97. Global Primary CD56+ NK Cells Consumption Value by Application (2024-2029) & (USD Million)
Table 98. Global Primary CD56+ NK Cells Average Price by Application (2018-2023) & (US$/Unit)
Table 99. Global Primary CD56+ NK Cells Average Price by Application (2024-2029) & (US$/Unit)
Table 100. North America Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 101. North America Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 102. North America Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 103. North America Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 104. North America Primary CD56+ NK Cells Sales Quantity by Country (2018-2023) & (K Units)
Table 105. North America Primary CD56+ NK Cells Sales Quantity by Country (2024-2029) & (K Units)
Table 106. North America Primary CD56+ NK Cells Consumption Value by Country (2018-2023) & (USD Million)
Table 107. North America Primary CD56+ NK Cells Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Europe Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 109. Europe Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 110. Europe Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 111. Europe Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 112. Europe Primary CD56+ NK Cells Sales Quantity by Country (2018-2023) & (K Units)
Table 113. Europe Primary CD56+ NK Cells Sales Quantity by Country (2024-2029) & (K Units)
Table 114. Europe Primary CD56+ NK Cells Consumption Value by Country (2018-2023) & (USD Million)
Table 115. Europe Primary CD56+ NK Cells Consumption Value by Country (2024-2029) & (USD Million)
Table 116. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 117. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 118. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 119. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 120. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Region (2018-2023) & (K Units)
Table 121. Asia-Pacific Primary CD56+ NK Cells Sales Quantity by Region (2024-2029) & (K Units)
Table 122. Asia-Pacific Primary CD56+ NK Cells Consumption Value by Region (2018-2023) & (USD Million)
Table 123. Asia-Pacific Primary CD56+ NK Cells Consumption Value by Region (2024-2029) & (USD Million)
Table 124. South America Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 125. South America Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 126. South America Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 127. South America Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 128. South America Primary CD56+ NK Cells Sales Quantity by Country (2018-2023) & (K Units)
Table 129. South America Primary CD56+ NK Cells Sales Quantity by Country (2024-2029) & (K Units)
Table 130. South America Primary CD56+ NK Cells Consumption Value by Country (2018-2023) & (USD Million)
Table 131. South America Primary CD56+ NK Cells Consumption Value by Country (2024-2029) & (USD Million)
Table 132. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Type (2018-2023) & (K Units)
Table 133. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Type (2024-2029) & (K Units)
Table 134. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Application (2018-2023) & (K Units)
Table 135. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Application (2024-2029) & (K Units)
Table 136. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Region (2018-2023) & (K Units)
Table 137. Middle East & Africa Primary CD56+ NK Cells Sales Quantity by Region (2024-2029) & (K Units)
Table 138. Middle East & Africa Primary CD56+ NK Cells Consumption Value by Region (2018-2023) & (USD Million)
Table 139. Middle East & Africa Primary CD56+ NK Cells Consumption Value by Region (2024-2029) & (USD Million)
Table 140. Primary CD56+ NK Cells Raw Material
Table 141. Key Manufacturers of Primary CD56+ NK Cells Raw Materials
Table 142. Primary CD56+ NK Cells Typical Distributors
Table 143. Primary CD56+ NK Cells Typical Customers
List of Figures
Figure 1. Primary CD56+ NK Cells Picture
Figure 2. Global Primary CD56+ NK Cells Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Primary CD56+ NK Cells Consumption Value Market Share by Type in 2022
Figure 4. Custom Made Examples
Figure 5. Bulk Examples
Figure 6. Global Primary CD56+ NK Cells Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Primary CD56+ NK Cells Consumption Value Market Share by Application in 2022
Figure 8. Compound Screening Examples
Figure 9. Immune Function Assay Examples
Figure 10. Drug Discovery Examples
Figure 11. Others Examples
Figure 12. Global Primary CD56+ NK Cells Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global Primary CD56+ NK Cells Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Primary CD56+ NK Cells Sales Quantity (2018-2029) & (K Units)
Figure 15. Global Primary CD56+ NK Cells Average Price (2018-2029) & (US$/Unit)
Figure 16. Global Primary CD56+ NK Cells Sales Quantity Market Share by Manufacturer in 2022
Figure 17. Global Primary CD56+ NK Cells Consumption Value Market Share by Manufacturer in 2022
Figure 18. Producer Shipments of Primary CD56+ NK Cells by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 19. Top 3 Primary CD56+ NK Cells Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Top 6 Primary CD56+ NK Cells Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Global Primary CD56+ NK Cells Sales Quantity Market Share by Region (2018-2029)
Figure 22. Global Primary CD56+ NK Cells Consumption Value Market Share by Region (2018-2029)
Figure 23. North America Primary CD56+ NK Cells Consumption Value (2018-2029) & (USD Million)
Figure 24. Europe Primary CD56+ NK Cells Consumption Value (2018-2029) & (USD Million)
Figure 25. Asia-Pacific Primary CD56+ NK Cells Consumption Value (2018-2029) & (USD Million)
Figure 26. South America Primary CD56+ NK Cells Consumption Value (2018-2029) & (USD Million)
Figure 27. Middle East & Africa Primary CD56+ NK Cells Consumption Value (2018-2029) & (USD Million)
Figure 28. Global Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 29. Global Primary CD56+ NK Cells Consumption Value Market Share by Type (2018-2029)
Figure 30. Global Primary CD56+ NK Cells Average Price by Type (2018-2029) & (US$/Unit)
Figure 31. Global Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 32. Global Primary CD56+ NK Cells Consumption Value Market Share by Application (2018-2029)
Figure 33. Global Primary CD56+ NK Cells Average Price by Application (2018-2029) & (US$/Unit)
Figure 34. North America Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 35. North America Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 36. North America Primary CD56+ NK Cells Sales Quantity Market Share by Country (2018-2029)
Figure 37. North America Primary CD56+ NK Cells Consumption Value Market Share by Country (2018-2029)
Figure 38. United States Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Canada Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Mexico Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Europe Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 42. Europe Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 43. Europe Primary CD56+ NK Cells Sales Quantity Market Share by Country (2018-2029)
Figure 44. Europe Primary CD56+ NK Cells Consumption Value Market Share by Country (2018-2029)
Figure 45. Germany Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. France Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. United Kingdom Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Russia Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Italy Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Asia-Pacific Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 51. Asia-Pacific Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 52. Asia-Pacific Primary CD56+ NK Cells Sales Quantity Market Share by Region (2018-2029)
Figure 53. Asia-Pacific Primary CD56+ NK Cells Consumption Value Market Share by Region (2018-2029)
Figure 54. China Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Japan Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Korea Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. India Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Southeast Asia Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Australia Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. South America Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 61. South America Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 62. South America Primary CD56+ NK Cells Sales Quantity Market Share by Country (2018-2029)
Figure 63. South America Primary CD56+ NK Cells Consumption Value Market Share by Country (2018-2029)
Figure 64. Brazil Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Argentina Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Middle East & Africa Primary CD56+ NK Cells Sales Quantity Market Share by Type (2018-2029)
Figure 67. Middle East & Africa Primary CD56+ NK Cells Sales Quantity Market Share by Application (2018-2029)
Figure 68. Middle East & Africa Primary CD56+ NK Cells Sales Quantity Market Share by Region (2018-2029)
Figure 69. Middle East & Africa Primary CD56+ NK Cells Consumption Value Market Share by Region (2018-2029)
Figure 70. Turkey Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Egypt Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Saudi Arabia Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. South Africa Primary CD56+ NK Cells Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Primary CD56+ NK Cells Market Drivers
Figure 75. Primary CD56+ NK Cells Market Restraints
Figure 76. Primary CD56+ NK Cells Market Trends
Figure 77. Porters Five Forces Analysis
Figure 78. Manufacturing Cost Structure Analysis of Primary CD56+ NK Cells in 2022
Figure 79. Manufacturing Process Analysis of Primary CD56+ NK Cells
Figure 80. Primary CD56+ NK Cells Industrial Chain
Figure 81. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 82. Direct Channel Pros & Cons
Figure 83. Indirect Channel Pros & Cons
Figure 84. Methodology
Figure 85. Research Process and Data Source